Showing results (21-30 of 207) with videos related to
Sort By:
Pageof 21
Acta Clinica Belgica|January 5, 2002
Therapy, glycaemic control and complications in type 1 diabetic patients: results from a single centre cohort of 465 subjectsS Deckers, M P Hermans, M BuysschaertActa Clinica Belgica|September 6, 2002
Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetesM P Hermans, C Dumont, M BuysschaertActa Clinica Belgica|January 1, 1997
[Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention]M Buysschaert, M Maes, M P HermansEuropean Heart Journal|August 1, 1991
Dopaminergic drugs in the management of chronic heart failureH Pouleur, J Raigoso, M F RousseauBritish Journal of Clinical Pharmacology|January 1, 1989
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitorsH Pouleur, C Hanet, M F RousseauEuropean Heart Journal|April 1, 1990
Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunctionH Pouleur, C Hanet, M F RousseauBiochimica Et Biophysica Acta|November 28, 1986
Role of the decrease in ionized calcium in the inhibition of insulin release by chloride-free solutionsM P Hermans, M Gérard, J C HenquinDiabetologia|August 1, 1987
The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse isletsM P Hermans, W Schmeer, J C HenquinEndocrinology|May 1, 1987
Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cellsM P Hermans, W Schmeer, J C HenquinDiabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M BuysschaertPageof 21